NASDAQ:HALO Shareholder Alert: Investigation over Potential Wrongdoing at Halozyme Therapeutics, Inc
March 27, 2018 at 13:00 PM EDT
San Diego, CA -- (SBWIRE) -- 03/27/2018 -- An investigation was announced for investors in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) over potential breaches of fiduciary duties by certain officers and directors at Halozyme Therapeutics.
